CDH2 and lung carcinoma: Consistent with this possibility, we found that siRNA-mediated silencing of GRP115 in the lung cancer cell lines resulted in upregulation of E-cadherin, an epithelial cell marker, and downregulation of the mesenchymal cell markers N-cadherin and Vimentin (Figure 6E).